Cargando…
Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity
BACKGROUND: Cyclin D1 (CCND1) regulates cell cycle progression during the late G1 and S phase and takes part in methotrexate metabolism. It was hypothesized that CCND1 gene polymorphism affects acute lymphoblastic leukemia (ALL) development, prognosis and may relate to methotrexate cytotoxicity. SUB...
Autores principales: | El Menshawy, Nadia, El Marghany, Ahmed B, Sarhan, Mohamed M, Aladle, Doaa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798150/ https://www.ncbi.nlm.nih.gov/pubmed/33112552 http://dx.doi.org/10.31557/APJCP.2020.21.10.2941 |
Ejemplares similares
-
Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma
por: Schernhammer, E S, et al.
Publicado: (2006) -
The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor
por: Ashton, Katie A, et al.
Publicado: (2008) -
Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Meta-Analysis
por: Li, Meng, et al.
Publicado: (2013) -
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
por: Luo, Tao, et al.
Publicado: (2016) -
Association between the Cyclin D(1) G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis
por: Meng, Yichen, et al.
Publicado: (2016)